RENU MULTI-PURPOSE SOLUTION
Report
- Report Number
- 1313525-2007-00023
- Event Type
- Injury
- Date Received
- January 18, 2007
- Report Date
- April 14, 2006
- Manufacturer
- BAUSCH & LOMB, INC.
- Product Code
- LPN
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NM, US
- Reporter Occupation
- OTHER
Narratives
BAUSCH & LOMB IS UNABLE TO COMPLETE AN INVESTIGATION OF THIS COMPLAINT SINCE NO PRODUCT WAS RETURNED AND NO LOT NUMBER WAS PROVIDED. HOWEVER, THE COMPANY DID INITIATE A BROADER INVESTIGATION OF REPORTED FUSARIUM KERATITIS EVENTS THAT EVALUATED THE MANUFACTURING FACILITY ENVIRONMENTAL RECORDS, A REVIEW OF BATCH RECORDS AND TESTING OF RETAIN SAMPLES FOR NUMEROUS PRODUCED PRODUCT LOTS. ALL OF THE RECORDS INDICATE THERE WERE NO ANOMALIES THAT COULD HAVE BEEN RELATED TO REPORTED FUSARIUM KERATITIS, THERE WERE NO FUSARIUM RECOVERIES FROM THE FACILITY ENVIRONMENTAL MONITORING PROGRAM OF THE ASEPTIC PROCESSING AREAS, AND ALL PRODUCTS EVALUATED MET RELEASE STERILITY CRITERIA. WHERE PRODUCT RETAIN SAMPLE TESTING WAS COMPLETED ALL CHEMICAL AND BIOCIDAL PERFORMANCE CRITERIA WERE EFFECTIVE AGAINST MICROBIAL CHALLENGES AS REQUIRED.
TELEPHONE CALL WAS RECEIVED FROM CONSUMER REPORTING SHE BELIEVED SHE HAD A CASE OF FUSARIUM INFECTION. CONSUMER REPORTED SHE WAS TREATED AT AN URGENT CARE CENTER AND WAS PRESCRIBED (UNSPECIFIED) ANTIBIOTIC EYE DROPS. AFTER SEVERAL CONTACTS WITH CONSUMER , SIGNED HEALTH INFORMATION AUTHORIZATION RECEIVED (LIMITING RECORDS TO BE RELEASED FROM JUNE 2005 TO JUNE 2006) AND SENT TO HEALTH SYSTEM CONSUMER IDENTIFIED-HEALTH SYSTEM RESPONDED NO MEDICAL RECORDS AFTER LAST SEEN IN JANUARY 2004. UNABLE TO OBTAIN MEDICAL RECORDS TO VERIFY REPORTED CASE OF FUSARIUM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | RENU MULTI-PURPOSE SOLUTION | MULTI-PURPOSE SOLUTION FOR SOFT CONTACT LENSES | LPN | BAUSCH & LOMB, INC. | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 36 YR | Required Intervention |